Full Text View
Tabular View
No Study Results Posted
Related Studies
To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar
This study has been completed.
Study NCT00876824   Information provided by Bharat Serums and Vaccines Limited

First Received on April 6, 2009.   Last Updated on June 1, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leishmaniasis, Visceral
Additional conditions recognized in this trial
Leishmaniasis
More general conditions related to this trial
Euglenozoa Infections
Parasitic Diseases
Protozoan Infections
Skin Diseases
Skin Diseases, Infectious
Skin Diseases, Parasitic
Interventions listed in this trial
Amphotericin B Lipid emulsion
Liposomal Amphotericin B
Additional drug interventions recognized in this trial
Amphotericin B
More general drug interventions related to this trial
Amebicides
Anti-Bacterial Agents
Anti-Infective Agents
Antifungal Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Bharat Serums and Vaccines Limited
Ministry of Science and Technology


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services